Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.9846
+0.0246 (2.56%)
At close: Mar 20, 2026, 4:00 PM EDT
0.9547
-0.0299 (-3.04%)
After-hours: Mar 20, 2026, 6:03 PM EDT
Standard BioTools Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Standard BioTools stock has a target of 1.35, which predicts a 37.11% increase from the current stock price of 0.98.
Price Target: $1.35 (+37.11%)
Analyst Consensus: Hold
* Price targets were last updated on Nov 5, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Standard BioTools is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $1.55 → $1.35 | Hold | Maintains | $1.55 → $1.35 | +37.11% | Nov 5, 2025 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 27, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $2.75 → $2.5 | Strong Buy | Maintains | $2.75 → $2.5 | +153.91% | Oct 31, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $3.5 → $2.75 | Strong Buy | Maintains | $3.5 → $2.75 | +179.30% | Aug 1, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates $3.5 | Strong Buy | Initiates | $3.5 | +255.47% | Apr 16, 2024 |
Financial Forecast
Revenue This Year
82.32M
from 85.33M
Decreased by -3.53%
Revenue Next Year
84.48M
from 82.32M
Increased by 2.63%
EPS This Year
-0.16
from -0.20
EPS Next Year
-0.15
from -0.16
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 86.3M | 89.8M | |
| Avg | 82.3M | 84.5M | |
| Low | 78.7M | 79.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.1% | 9.1% | |
| Avg | -3.5% | 2.6% | |
| Low | -7.8% | -3.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.17 | -0.15 | |
| Avg | -0.16 | -0.15 | |
| Low | -0.16 | -0.15 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.